Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3622 Target Snapshot

Cytochrome P450 2C19 · SINGLE PROTEIN · Homo sapiens

23,184Compounds
2,452Assays
69Approved Drugs
5,859.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P33261. Use UniProt P33261 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P33261 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 2C19 as ChEMBL target CHEMBL3622, mapped to UniProt P33261. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 2C19
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3622
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P33261
Cytochrome P450 2C19
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 2C19 is the right protein anchor across sources, using UniProt P33261 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 2C19
UniProt AccessionP33261
Component TypeProtein
Sequence Length490 aa

Cytochrome P450 2C19

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 2C19, mapped to UniProt P33261. Sequence length is 490 aa.

Mapped IDP33261
Review nameCytochrome P450 2C19
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

69
Approved
17
Phase III
33
Phase II
13
Phase I
Assay Mix

Activity Type Distribution

IC504,910.0
KI923.0
EC5026.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL91 10.7 IC50 0.02 Approved
CHEMBL4593464 8.34 IC50 4.6 Preclinical
CHEMBL5561914 8.29 IC50 5.1 Preclinical
CHEMBL112532 8.15 IC50 7.0 Preclinical
CHEMBL1098230 8.07 IC50 8.5 Preclinical
CHEMBL5278512 8.05 IC50 9.0 Preclinical
CHEMBL4557596 8.04 IC50 9.1 Preclinical
CHEMBL1221 7.8 IC50 16.0 Approved
CHEMBL998 7.8 IC50 16.0 Approved
CHEMBL104 7.8 IC50 16.0 Approved
Distribution

pChEMBL Value Distribution

496
5.0
255
5.5
139
6.0
77
6.5
45
7.0
13
7.5
8
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CANNABIDIOL
CHEMBL190461
Approved 2018
IDEBENONE
CHEMBL252556
Approved 2015
RILPIVIRINE
CHEMBL175691
Approved 2011
ETRAVIRINE
CHEMBL308954
Approved 2008
LANSOPRAZOLE
CHEMBL480
Approved 1995
LORATADINE
CHEMBL998
Approved 1993
FINASTERIDE
CHEMBL710
Approved 1992
SERTRALINE
CHEMBL809
Approved 1991
TICLOPIDINE
CHEMBL833
Approved 1991
OXICONAZOLE
CHEMBL1262
Approved 1988
NICARDIPINE
CHEMBL1484
Approved 1988
FLUOXETINE
CHEMBL41
Approved 1987
SULCONAZOLE
CHEMBL1221
Approved 1985
ECONAZOLE
CHEMBL808
Approved 1982
CLEMASTINE
CHEMBL1626
Approved 1977
FLUORESCEIN
CHEMBL1057
Approved 1976
OXYBUTYNIN
CHEMBL1231
Approved 1975
CLOTRIMAZOLE
CHEMBL104
Approved 1975
MICONAZOLE
CHEMBL91
Approved 1974
NORETHINDRONE ACETATE
CHEMBL1201146
Approved 1973
STANOZOLOL
CHEMBL2079587
Approved 1962
PHENELZINE
CHEMBL1089
Approved 1961
TROPICAMIDE
CHEMBL1200604
Approved 1960
Assay Landscape

Assay Landscape

2,452
Total Assays
1,452
Tested Compounds
3
Assay Types
ADME — 2,403 assays, 1,452 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1,434 895 5.3
microsome format 478 380 5.2
assay format 385 127 5.2
cell-based format 59 26 4.7
tissue-based format 43 24 5.3
cell membrane format 4 0
Binding — 48 assays, 218 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 22 117 5.2
assay format 14 28 5.0
tissue-based format 8 25 4.8
microsome format 3 0
cell-based format 1 48 6.1
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine